← Leaderboards
Kimberly A. Kelly
University Of Virginia
$7,276,942
Attributed
$13,503,745
Total exposure
10
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2008–25$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,503,745 · 10
By mechanism
R01$9,297,773 · 5
T32$2,996,301 · 1
R21$1,162,900 · 3
P30$46,771 · 1
Top collaborators
- Victor H. Engelhard10 shared
- Silvia Salinas Blemker6 shared
- Nabeel Bardeesy4 shared
- Brent A French4 shared
- Craig D Logsdon4 shared
- Julie L Sutcliffe3 shared
- Rebecca R Pompano2 shared
Most similar at University Of Virginia
Same institution · by research overlap
- Brent A French$10,427,669
- Justin S. Hanes$23,093,683
- Richard J Price$15,866,868
- Thomas P Loughran$27,014,958
- Jeffrey Chunlong Xing$185,468
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsBaseTechnologyTumorEngineeringGenerationsTissuesTreatment EfficacyAffinityPhage DisplayBiologyFlow CytometryMalignant NeoplasmsIn VivoProteinsResponseResearch PersonnelPeptidesLigandsMolecular ImagingMalignant Neoplasm Of PancreasSpecificityImageSuccess
Grant awards (37)
Biotechnology for Human Health$426,360
T32 · FY2025 · GM · contact PI
CRX - Project$46,771
P30 · FY2025 · CA · contact PI
Biotechnology Training Program$549,359
T32 · FY2024 · GM
Biotechnology Training Program$530,535
T32 · FY2023 · GM
Manipulating microenvironment and vasculature to enhance T cell infiltration into tumors$507,168
R01 · FY2023 · CA
Manipulating microenvironment and vasculature to enhance T cell infiltration into tumors$31,373
R01 · FY2023 · CA
Biotechnology Training Program$520,362
T32 · FY2022 · GM
Manipulating microenvironment and vasculature to enhance T cell infiltration into tumors$507,168
R01 · FY2022 · CA
Towards GLIMPSE: Enabling technology to map cytokines in inflamed tissue$184,760
R21 · FY2022 · AI
Manipulating microenvironment and vasculature to enhance T cell infiltration into tumors$134,987
R01 · FY2022 · CA
Manipulating microenvironment and vasculature to enhance T cell infiltration into tumors$655,260
R01 · FY2021 · CA
Biotechnology Training Program$487,629
T32 · FY2021 · GM
Towards GLIMPSE: Enabling technology to map cytokines in inflamed tissue$225,135
R21 · FY2021 · AI
Biotechnology Training Program$482,056
T32 · FY2020 · GM
Manipulating microenvironment and vasculature to enhance T cell infiltration into tumors$479,627
R01 · FY2020 · CA
Supplement - Manipulating microenvironment and vasculature to enhance T cell infiltration into tumors$105,729
R01 · FY2020 · CA
Targeted Molecular Imaging of Plectin-1; Bench to bedside and back again$573,198
R01 · FY2019 · CA
Manipulating microenvironment and vasculature to enhance T cell infiltration into tumors$517,519
R01 · FY2019 · CA
Taste Receptor Family 2 Member 9 as a novel target for imaging Cancer Associated Fibroblasts in pancreatic cancer$170,361
R21 · FY2019 · CA · contact PI
Targeted Molecular Imaging of Plectin-1; Bench to bedside and back again$617,985
R01 · FY2018 · CA
Taste Receptor Family 2 Member 9 as a novel target for imaging Cancer Associated Fibroblasts in pancreatic cancer$210,703
R21 · FY2018 · CA · contact PI
Targeted Molecular Imaging of Plectin-1; Bench to bedside and back again$524,668
R01 · FY2017 · CA
Highly Specific and Efficient Vectors for Targeting Pancreatic Cancer$489,556
R01 · FY2017 · CA · contact PI
Highly Specific and Efficient Vectors for Targeting Pancreatic Cancer$489,556
R01 · FY2016 · CA · contact PI
Highly Specific and Efficient Vectors for Targeting Pancreatic Cancer$489,556
R01 · FY2015 · CA · contact PI
Fluorescence molecular tomography to study T cell infiltration into tumors$168,788
R21 · FY2015 · CA
Highly Specific and Efficient Vectors for Targeting Pancreatic Cancer$504,056
R01 · FY2014 · CA · contact PI
Fluorescence molecular tomography to study T cell infiltration into tumors$203,153
R21 · FY2014 · CA
Development of Molecularly Targeted Imaging Agents for KRAS activity in vivo$325,984
R01 · FY2013 · EB · contact PI
Development of Molecularly Targeted Imaging Agents for KRAS activity in vivo$345,912
R01 · FY2012 · EB · contact PI
Development of Molecularly Targeted Imaging Agents for Early Detection of PDAC$248,508
R01 · FY2012 · CA · contact PI
Development of Molecularly Targeted Imaging Agents for KRAS activity in vivo$346,127
R01 · FY2011 · EB · contact PI
Development of Molecularly Targeted Imaging Agents for Early Detection of PDAC$248,508
R01 · FY2011 · CA · contact PI
Development of Molecularly Targeted Imaging Agents for KRAS activity in vivo$372,465
R01 · FY2010 · EB · contact PI
Development of Molecularly Targeted Imaging Agents for Early Detection of PDAC$256,194
R01 · FY2010 · CA · contact PI
Development of Molecularly Targeted Imaging Agents for Early Detection of PDAC$256,669
R01 · FY2009 · CA · contact PI
Development of Molecularly Targeted Imaging Agents for Early Detection of PDAC$270,000
R01 · FY2008 · CA · contact PI